Caleminder Inc.

CMND

US12890A1051

Internet Services

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

20/06	Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD	MT
23/02	Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder	MT

Caleminder Inc. Announces Resignation of David Lamadrid as Director and Officer

July 07, 2017 at 02:56 am IST

David Lamadrid has resigned as a director and officer of Caleminder Inc. effective as of the close of business on July 6, 2017.

Latest news about Caleminder Inc.

Clearmind Medicine Signs Agreement to Secure Global Rights for Psychedelic Compound Development, Commercialization for PTSD	20/06	MT
Clearmind Medicine Says Israel Approves Start of Clinical Trial of CMND-100 for Alcohol Use Disorder	23/02	MT
Clearmind Medicine Receives Patent Approval in China	05/02	MT
Sector Update: Health Care	12/01	MT
Top Midday Decliners	12/01	MT
Top Premarket Decliners	11/01	MT
Top Midday Gainers	11/01	MT
Sector Update: Health Care Stocks Ease Late Afternoon	06/12	MT
Top Midday Gainers	06/12	MT
Top Premarket Gainers	30/11	MT
Sector Update: Health Care Stocks Retreat in Late Afternoon	29/11	MT
Top Midday Gainers	29/11	MT
Clearmind Medicine Closes $2.25 Million Public Offering Exclusive to US	18/23/18	MT
Sector Update: Health Care Stocks Rising Late Afternoon	15/23/15	MT
Sector Update: Health Care Stocks Rising in Afternoon Trading	14/23/14	MT
Sector Update: Health Care	14/23/14	MT
Clearmind Medicine Prices $2.25 Million Public Offering	14/23/14	MT
Sector Update: Health Care Stocks Falling Late Afternoon	07/23/07	MT
Sector Update: Health Care Stocks Down in Afternoon Trading	06/23/06	MT
Clearmind Adds Johns Hopkins University For CMND-100 Trial in Patients With Alcohol Use Disorder	06/23/06	MT
Scisparc, Clearmind Medicine to Evaluate Combination Treatment for Obesity, Metabolic Syndrome	16/23/16	MT
Top Premarket Gainers	26/23/26	MT
Clearmind Medicine Hires Contract Research Organization to Help With Alcohol Use Disorder Clinical Trial	20/23/20	MT
Clearmind Medicine Closed US$3.5 Million Public Offering, Which Was Not Made In Canada, and No Canadian Residents Took Part	07/23/07	MT
Sector Update: Health Care Stocks Steady to Lower in Late Afternoon	05/23/05	MT

Caleminder Inc. is a United States-based development-stage company. The Company has developed an online service, www.caleminder.net, which provides a calendar- based greeting and reminder service to assist subscribers in remembering life events, such as birthdays and anniversaries. The Company's service enables the users register with the system, and let them enter these dates, as well as configure a range of settings, including when they want to be notified, such as one month prior, two weeks prior or one week prior. The Company's application is Web-based and not available as a mobile download application. It focuses on offering the for-pay users the opportunity to upload a video or tape an audio message that is attached to the e-mail or included in a link. It is focused on creating an interface that enable the end user to customize various factors within the notification.

Sector

Internet Services

More about the company

Sector Social Media & Networking

	1st Jan change	Capi.
CALEMINDER INC.	-.--%	11.92M
META PLATFORMS, INC.	+52.53%	1,370B
TENCENT MUSIC ENTERTAINMENT GROUP	+61.27%	22.65B
MATCH GROUP, INC.	-19.40%	7.82B
WEIBO CORPORATION	-24.93%	2B
BUMBLE INC.	-36.64%	1.18B
NEXTDOOR HOLDINGS, INC.	+35.98%	1B
GREE, INC.	-5.26%	575M
NEW WORK SE	-15.99%	403M
ZIGEXN CO., LTD.	+9.79%	372M

Social Media & Networking

Caleminder Inc.

Equities

CMND

US12890A1051

Internet Services

Caleminder Inc. Announces Resignation of David Lamadrid as Director and Officer

Latest news about Caleminder Inc.

Chart Caleminder Inc.

Company Profile

Sector Social Media & Networking